• $1.9M
    Market Cap
  • -24.93%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
39,518
+345.27%
8,875
-85.32%
60,460
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Gross Profit
39,518
+345.27%
8,875
-85.32%
60,460
N/A
0
N/A
Sales and Marketing Expense
2.2M
-45.18%
4.1M
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-125,496
-18.35%
-153,697
-46.05%
-284,869
-33.24%
-426,708
N/A
Depreciation and Amortization Expense
394,446
0.00%
394,446
-81.11%
2.1M
+12,948.61%
16,001
N/A
Total Operating Expenses
2.8M
-40.14%
4.7M
-66.79%
14.0M
+183.60%
4.9M
N/A
Operating Profit
-2.8M
-40.88%
-4.7M
-66.71%
-14.0M
+182.38%
-4.9M
N/A
Interest Income
0
+100.00%
-257
-125.05%
1,026
+252.00%
-675
N/A
Interest Expense
-1.0M
-39.42%
-1.7M
+585.03%
-247,792
+5.55%
-234,754
N/A
Interest Income and Expense and Net
-1.0M
-39.43%
-1.7M
+587.98%
-246,766
+4.82%
-235,429
N/A
Total Nonoperating Income and Expense
5.3M
+233.85%
1.6M
-22.40%
2.0M
+252.75%
-1.3M
N/A
Income before Taxes
-8.1M
+29.10%
-6.2M
-61.04%
-16.0M
+154.73%
-6.3M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
6.0M
N/A
N/A
N/A
Net Income
-8.1M
+29.10%
-6.2M
-61.06%
-16.0M
+150.12%
-6.4M
N/A
Net Income from Continuing Operations Applicable to Common
-8.1M
+29.10%
-6.2M
-61.04%
-16.0M
+154.73%
-6.3M
N/A
Basic EPS and Net Income
-0.04
-200.00%
0.04
+133.33%
-0.12
+100.00%
-0.06
N/A
Diluted EPS and Net Income
-0.04
-200.00%
0.04
+133.33%
-0.12
+100.00%
-0.06
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
110.4M
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
110.4M
N/A
Balance Sheet
Cash and Cash Equivalents
156,457
+230.90%
47,282
-89.56%
452,963
-0.92%
457,181
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
156,457
+230.90%
47,282
-89.56%
452,963
-0.92%
457,181
N/A
Total Current Assets
156,457
+50.47%
103,979
-83.67%
636,613
-10.73%
713,104
N/A
Accumulated Depreciation
122,725
+36.13%
90,152
+54.18%
58,473
N/A
N/A
N/A
Property and Plant and Equipment and Net
134,067
+42.87%
93,840
-19.66%
116,810
+12.22%
104,094
N/A
Total Long-Term Assets
3.8M
-4.56%
4.0M
-12.16%
4.6M
-56.46%
10.5M
N/A
Total Assets
4.1M
-2.15%
4.2M
-20.88%
5.3M
-52.95%
11.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
0
-100.00%
5.1M
+21.69%
4.2M
N/A
Total Current Liabilities
6.0M
+76.22%
3.4M
+31.44%
2.6M
+72.50%
1.5M
N/A
Total Long-Term Debt
5.7M
+125.58%
2.5M
+122.76%
1.1M
-32.79%
1.7M
N/A
Total Long-Term Liabilities
5.8M
+2.74%
5.6M
+11.11%
5.1M
-38.43%
8.3M
N/A
Total Liabilities
11.8M
+30.33%
9.0M
+17.96%
7.7M
-21.41%
9.7M
N/A
Retained Earnings
-72.2M
+12.57%
-64.1M
+10.79%
-57.9M
+38.31%
-41.8M
N/A
Total Stockholders Equity
-7.7M
+58.67%
-4.8M
+106.37%
-2.3M
-249.33%
1.6M
N/A
Total Shares Outstanding
245.9M
+27.79%
192.4M
+39.35%
138.1M
+10.19%
125.3M
N/A
Cash Flow
Cash from Operating Activities
-1.0M
-49.59%
-2.0M
-17.79%
-2.5M
-22.67%
-3.2M
N/A
Capital Expenditures
0
-100.00%
8,710
-78.49%
40,495
N/A
N/A
N/A
Cash from Investing Activities
0
+100.00%
-8,710
-82.75%
-50,495
-605.96%
9,980
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.1M
-30.82%
1.6M
-34.97%
2.5M
-19.62%
3.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-6,960.98%
-86.72%
-52,425.60%
+126.81%
-23,114.45%
N/A
N/A
N/A
Return on Assets
-193.43%
+47.72%
-130.94%
-32.06%
-192.72%
+95.53%
-98.57%
N/A
Return on Equity
129.14%
-25.91%
174.30%
-95.80%
4,151.41%
+1,582.15%
246.79%
N/A
Revenue Growth
345.27%
+504.68%
-85.32%
N/A
N/A
N/A
-100.00%
N/A
Current Ratio
0.03
-14.38%
0.03
-87.60%
0.25
-48.24%
0.48
N/A
Cash Ratio
0.03
+88.49%
0.01
-92.08%
0.18
-42.55%
0.31
N/A
Debt-to-Equity Ratio
N/A
N/A
-0.52
-80.34%
-2.65
-171.01%
3.73
N/A
Debt-to-Assets Ratio
N/A
N/A
0.60
-48.73%
1.16
+125.36%
0.52
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow